The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-[(E)-but-2-enyl]-4-[3-chloro-4-(morpholine-4-carbonyl)phenyl]-2-methyl-1H-pyrrolo[2,3-c]pyridin-7-one ID: ALA5285110
Max Phase: Preclinical
Molecular Formula: C23H24ClN3O3
Molecular Weight: 425.92
Associated Items:
Names and Identifiers Canonical SMILES: C/C=C/Cn1cc(-c2ccc(C(=O)N3CCOCC3)c(Cl)c2)c2cc(C)[nH]c2c1=O
Standard InChI: InChI=1S/C23H24ClN3O3/c1-3-4-7-27-14-19(18-12-15(2)25-21(18)23(27)29)16-5-6-17(20(24)13-16)22(28)26-8-10-30-11-9-26/h3-6,12-14,25H,7-11H2,1-2H3/b4-3+
Standard InChI Key: IHZXYEFDJOXHGJ-ONEGZZNKSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
-0.3340 2.4739 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3805 2.8862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0924 2.4744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0924 1.6492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3822 1.2374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3340 1.6455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3822 0.4122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0968 -0.0005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0961 -0.8232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3812 -1.2359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3306 -0.8268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3353 -0.0020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3812 -2.0612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0959 -2.4737 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3333 -2.4737 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3333 -3.2989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0479 -3.7115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7625 -3.2989 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7625 -2.4737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0479 -2.0612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8753 1.4033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3673 2.0709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8966 2.7245 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3805 3.7115 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0486 2.8866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7633 2.4739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4779 2.8866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1925 2.4739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1925 2.0709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8107 -1.2359 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
7 5 1 0
8 7 2 0
9 8 1 0
10 9 2 0
11 10 1 0
12 11 2 0
7 12 1 0
10 13 1 0
13 14 2 0
13 15 1 0
16 15 1 0
17 16 1 0
18 17 1 0
19 18 1 0
20 19 1 0
15 20 1 0
4 21 1 0
21 22 2 0
23 22 1 0
3 23 1 0
2 24 2 0
1 25 1 0
25 26 1 0
26 27 2 0
27 28 1 0
22 29 1 0
9 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 425.92Molecular Weight (Monoisotopic): 425.1506AlogP: 4.01#Rotatable Bonds: 4Polar Surface Area: 67.33Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.84CX Basic pKa: ┄CX LogP: 2.98CX LogD: 2.98Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.64Np Likeness Score: -1.16
References 1. Crawford TD, Vartanian S, Côté A, Bellon S, Duplessis M, Flynn EM, Hewitt M, Huang HR, Kiefer JR, Murray J, Nasveschuk CG, Pardo E, Romero FA, Sandy P, Tang Y, Taylor AM, Tsui V, Wang J, Wang S, Zawadzke L, Albrecht BK, Magnuson SR, Cochran AG, Stokoe D.. (2017) Inhibition of bromodomain-containing protein 9 for the prevention of epigenetically-defined drug resistance., 27 (15): [PMID:28606761 ] [10.1016/j.bmcl.2017.05.063 ]